← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Proteotech, Inc.
Kirkland, WA
$12,981,071
Total funding
11
Grants
Funding over time
peak $1.2M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$12,981,071 · 11
By mechanism
R44$10,705,766 · 5
R43$2,275,305 · 6
Investigators at Proteotech, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Tau Protein Aggregation Inhibitors for Tauopathies$1,236,507
R44 · FY2014 · AG
Tau Protein Aggregation Inhibitors for Tauopathies$1,081,413
R44 · FY2013 · AG
Laminin-Derived Protein Fragments as Inhibitors of Alzheimer's Amyloidosis$948,839
R44 · FY2006 · AG
Amyloid Inhibiting Agent for Treatment of Alzheimer's$856,119
R44 · FY2002 · AG
Laminin-Derived Protein Fragments as Inhibitors of Alzheimer's Amyloidosis$822,374
R44 · FY2007 · AG
Amyloid Inhibiting Agent for Treatment of Alzheimer's$789,141
R44 · FY2001 · AG
Identification of Novel Small Molecules as Tau Protein Aggregation Inhibitors for$770,675
R43 · FY2011 · AG
Inhibitors of Alzheimer's Disease Amyloidosis$739,902
R44 · FY2002 · AG
Proteoglycans/Glycosaminoglycans in APP Transgenic Mice$520,841
R43 · FY2004 · AG
Systemic AA Amyloidosis Inhibitors$519,410
R44 · FY2009 · AR
Laminin-Derived Protein Fragments as Inhibitors of Alzheimer's Amyloidosis$516,960
R44 · FY2008 · AG
Inhibitors of Alzheimer's Disease Amyloidosis$508,020
R44 · FY2003 · AG
Alzheimer's Amyloid Plaque Persistence In Vivo$491,293
R44 · FY2002 · AG
Alzheimer's Amyloid Plaque Persistence In Vivo$485,177
R44 · FY2001 · AG
Systemic AA Amyloidosis Inhibitors$420,791
R44 · FY2008 · AR
Systemic AA Amyloidosis Inhibitors$390,262
R44 · FY2010 · AR
Amyloid Inhibiting Agent for Treatment of Alzheimer's$299,153
R44 · FY2004 · AG
ALZHEIMER'S AMYLOID PLAQUE PERSISTENCE IN VIVO$272,398
R43 · FY2000 · AG
Systemic AA Amyloidosis Inhibitors$264,984
R43 · FY2004 · AR
INHIBITORS OF ALZHEIMER'S DISEASE AMYLOIDOSIS$249,401
R43 · FY2000 · AG